What does this TikTok actually show?
The video appears to feature a before-and-after transformation attributed to Wegovy (semaglutide). While we can't access the specific content, the hashtags suggest claims about weight loss, muscle building, and physical transformation using this GLP-1 medication.
Transformation videos flood social media, but they rarely show the full picture. Most don't mention timeline, dosing, diet changes, or exercise routines that contributed to results.
The creator uses hashtags like #musculation (bodybuilding) alongside #wegovy, suggesting they're combining the medication with resistance training. That's actually smart, though we can't verify their specific approach from hashtags alone.
Does semaglutide really deliver these results?
The STEP 1 trial (Wilding et al., NEJM, 2021) found 14.9% average weight loss with 2.4mg semaglutide over 68 weeks. That's substantial but highly variable between individuals.
The STEP 4 trial showed people regained about two-thirds of lost weight within a year of stopping treatment. This isn't a quick fix that maintains itself.
Real results take time. The medication works by slowing gastric emptying and reducing appetite through GLP-1 receptor activation. You'll typically start at 0.25mg weekly and titrate up to 2.4mg over 16-20 weeks.
What about the muscle building claims?
Here's where transformation posts get misleading. Semaglutide doesn't build muscle. Period. The STEP 1 trial participants lost both fat and lean mass, though fat loss predominated.
Any muscle gains came from resistance training, not the medication. The drug actually reduces overall caloric intake, which can make muscle building harder without deliberate protein focus and progressive overload.
Combining GLP-1 agonists with strength training makes sense for body composition, but the medication deserves credit for appetite control and weight loss, not muscle growth. Don't confuse correlation with causation.
What's missing from these transformation videos?
Timeline matters enormously. The STEP trials ran 68-104 weeks. Most TikTok transformations don't specify whether changes took 6 months or 2 years.
Side effects get conveniently omitted. Nausea affected 44% of participants in STEP 1, with 4.5% stopping treatment due to gastrointestinal issues. That's not exactly #glowup material.
Cost and access aren't hashtag-friendly either. Wegovy runs $1,300+ monthly without insurance coverage. Many insurers still don't cover it for weight management.
Should you trust transformation content for medical decisions?
Absolutely not. Individual results vary wildly, and social media selects for the most dramatic outcomes. You're seeing show reels, not typical experiences.
The creator might have genuinely good results, but their experience doesn't predict yours. Factors like baseline weight, adherence, diet quality, exercise routine, and genetic variation all influence outcomes.
Talk to a healthcare provider about whether semaglutide fits your situation. Don't let TikTok transformations drive medical decisions, even inspiring ones.